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Layer chickensere previously isolated from commercial layer chicken ﬂocks and shown to be
phylogenetically related to vaccine strains but pathogenic in susceptible chickens. In this study, their viral
genomes were sequenced and compared to sequences of vaccines being used in those ﬂocks. The vaccine
strains examined were sequenced directly from the manufacturer and had identical genome segment B
sequences. Compared to these vaccines, the GA-1, H-30 and CS-2-35 isolates each had one silent mutation in
the gene that encodes VP1. Compared to the two vaccines used at the time CS-2-35was isolated, the segment A
sequence of CS-2-35 contained numerous nucleotide and amino acid mutations suggesting the CS-2-35 virus
was not closely related to these vaccines. This virus however did have amino acid mutations in VP2 that are
reported to be necessary for replication in cell culture and lacked two of the three amino acid mutations
previously shown to be necessary for virulence. These data suggest that CS-2-35 was a descendant from an
attenuated strain of IBDV. When the segment A genomic sequences of the GA-1 and H-30 viruses were
compared to the vaccines being used in those ﬂocks they were most closely related to the attenuated D78
vaccine strain. In genome segment A, three nucleotide mutations in GA-1 and four in H-30 were observed
compared to the D78 classic vaccine. These nucleotide mutations caused one amino acid (H253N) change in
the GA-1 virus and two amino acids (H253Q and G259D) were different in the H-30 virus. In addition, both the
GA-1 and H-30 viruses had the amino acid G76 in VP2 that appears to be unique to the vaccine D78. The data
suggest that GA-1 and H-30 are genetically related and have a common ancestor even though they were
isolated from geographically distant ﬂocks. The evidence also suggests that GA-1, H-30 and CS-2-35 could be
reversions from attenuated vaccine viruses or by coincidence genetically resemble classic IBDV vaccines. It
should be noted that some of the classic virus vaccines were not being used according to the manufacturer's
recommendations at the time the GA-1, H-30 and CS-2-35 strains were isolated. Together, the molecular and
pathogenicity data indicate that a single amino acid mutation from Histidine (H) to Glutamine (Q) or
Asparagine (N) at position 253 in VP2 will markedly increase the virulence of an attenuated IBDV.
© 2008 Elsevier Inc. All rights reserved.IntroductionInfectious bursal disease (IBD) in chickens is caused by infectious
bursal disease virus (IBDV). These viruses have been found to naturally
range in virulence from attenuated to very virulent (vvIBDV). The
vvIBDV designation is usually reserved for those viruses that cause
high mortality. Although the degree of pathogenicity among vvIBDV
strains generally correlates with morbidity and mortality, the disease
caused by non-vvIBDV strains can range from a clinical disease with
hemorrhagic lesions, severe lymphocyte depletion and low mortality
to a sub-clinical disease. Viruses that cause sub-clinical disease caninfectious bursal disease virus;
n; B-BW, bursa–body weight;
hic effects.
).
l rights reserved.also be immunosuppressive (Sharma et al., 2000). Thus, deﬁning
pathogenicity and virulence among non-vvIBDV strains can be
challenging. A characteristic common to all IBDV strains is the
potential to cause immunosuppression which can lead to devastating
losses for the broiler and egg industries. Regardless of the clinical
nature of the disease, the amount of damage to the bursa of Fabricius
characterized by lymphocyte depletion, inﬂammation, and reduction
in bursa/body-weight ratios is a good measure of virulence and has
been used in many studies (Brandt et al., 2001; Rautenschlein et al.,
2003; Raue et al., 2004a; Boot et al., 2000; Le Nouen et al., 2006; Liu
and Vakharia, 2004).
Infectious bursal disease viruses can also cause a range of
histopathological lesions in the bursa; from attenuated forms of the
virus that cause little or no lymphocyte depletion, to pathogenic forms
that cause massive lymphocyte depletion, hemorrhage and inﬂam-
mation. Passing pathogenic strains of the virus in cell culture has been
used to attenuate IBDV (Yamaguchi et al., 1996a; Zierenberg et al.,
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prone to mutation, there is a potential risk that an attenuated IBDV
will revert to a more virulent state when replicating in poultry.
Reversion of IBDV has been described by Raue and co-workers (Raue
et al. (2004b). Using site-directed mutagenesis, they partially
attenuated a vvIBDV strain. Following inoculation of commercial
chickens, the mutant strain reverted to the wild-type phenotype
during replication in the bursa of Fabricius. They concluded that
several rounds of IBDV replication provided the opportunity for the
mutant virus to revert to the very virulent phenotype.
Reverse genetic studies have shown that amino acids 253 and284 in
VP2 are involved in virulence and cell tropism of IBDV (Boot et al., 2000;
Mundt, 1999; van Loon et al., 2002; Liu and Vakharia, 2004). In another
study, the amino acids 253, 279 and 284 were reported to control
virulence and cell tropism (Brandt et al., 2001). Evidence that VP2 is not
the sole determinant of virulence in vvIBDV was reported (Boot et al.,
2000). More recently it was shown that segment B which encodes the
viral RNA-directed RNA polymerase was important for efﬁcient viral
replication andvirulence in vivo (Liu andVakharia, 2004). Thediscovery
of a natural reassortant of IBDV also demonstrated that segment B may
be important for the pathogenicity of vvIBDV strains (Le Nouen et al.,
2006). Together, these studies suggest that more than one molecular
determinant contributes to the virulence of IBDV.
Recently we reported on viruses isolated from commercial layer
chicken ﬂocks that were shown to be pathogenic in speciﬁc pathogen-
free chickens (Sreedevi et al., 2007). The molecular and phylogenic
analysis however indicated that they were very closely related to
vaccine strains of IBDV. The purpose of this study was to examine the
molecular and phenotypic characteristics of these naturally occurring
IBDV isolates and to compare them to attenuated forms of the virus.
The results indicate that a single amino acid substitution at position
253 can increase the virulence of IBDV. This is signiﬁcant because it
suggests that a relatively minor change has the potential to contribute
to the reversion of attenuated IBDV strains.
Results
Nucleotide sequence analysis
In a previous study, nucleotide sequences of the GA-1, CS-2-35 and
H-30 viruses were determined across the hypervariable region of the
VP2 gene (Sreedevi et al., 2007). The results indicated that the viruses
were very similar tovaccine strains of IBDVbeingused in thoseﬂocks. To
determinehowclosely related theywere to the IBDVvaccines, the entire
sequences of genome segments A and B were determined for the three
viruses. The isolates were RT-PCR ampliﬁed and sequenced directly
from the layer ﬂock samples. Since D78 was being used in the GA-1 and
H-30 origin ﬂocks, we also sequenced that vaccine virus in its entirety
directly froma vial of vaccine from themanufacturer. The ViBursaG and
ViBursa CE vaccines being used in the CS-2-35 origin ﬂock were also
sequenced in their entirety. These vaccine viruses used for sequencing
were also obtained directly from a commercial vaccine vial.
The genome segment B nucleotide sequences code for the RNA-
directed RNA polymerase (VP-1). The D78, ViBursa G and ViBursa CE
segment B sequences were identical to each other. Compared to these
vaccines, the GA-1 virus had one silentmutation at nucleotide position
2511 (C→T) and the CS-2-35 andH-30 viruses had one silentmutation
at nucleotide position 72 (C→T). Segment B sequence numbering was
based on the Cu-1 strain (AF362775). Because all the segment B
nucleotide mutations were silent, the amino acid sequences of VP1 for
D78, ViBursa G, ViBursa CE, GA-1, CS-2-35 and H-30 were identical.
The nucleotide sequence of the D78 genome segment A was
determined and compared to GA-1 and H-30 since this vaccine was
used in these two ﬂocks. The vaccine Bursine 2 was also used in the
GA-1 and H-30 ﬂocks but its sequence was very different compared to
the GA-1 and H-30 viruses (Sreedevi et al., 2007). Genome segment Anucleotide sequence numbers are based on those reported by Bayliss
and co-workers (Bayliss et al. (1990). Compared to D78, segment A of
GA-1 had three nucleotide changes at 888 (C→A), 2213 (C→T) and
2236 (A→G). The 2213 and 2236 mutations were silent; the 888
mutation caused a change in amino acid 253 (H→N) of VP2. The H-30
virus had nucleotide mutations at 890 (C→A), 904 (G→A), 2213
(C→T) and 2236 (A→G) compared to D78. Like GA-1, the 2213 and
2236 mutations were silent. The 890 mutation caused a change in
amino acid 253 (H→Q) and 904 caused a change in amino acid 258
(G→D) of VP2.
The nucleotide sequences of genome segment A of ViBursa G and
ViBursa CE were determined and compared to the CS-2-35 isolate
since theywere used in that ﬂock. The genome segment A sequence of
the CS-2-35 isolate was more closely related to ViBursa G (52 base
changes, 98.39% identity) compared to ViBursa CE (63 base changes,
98.05% identity). However, the CS-2-35 genome segment A sequence
was most closely related to D78; a vaccine not being used at the time
this virus was isolated. It had 5 nucleotidemutations compared to D78
(99.85% identity). Compared to D78, the two silent mutations at 2213
(C→T) and 2236 (A→G) observed in the GA-1 virus were also present
in CS-2-35. In addition CS-2-35 had mutations at 357 (G→A), 890
(C→A) and 936 (A→G). The CS-2-35 mutation at 357 caused a
substitution in amino acid 76 (G→S), nucleotide mutation 890 caused
a change in amino acid 253 (H→Q) and 936 caused a change in amino
acid 269 (T→A). Thus, compared to the D78 polyprotein, three amino
acid substitutions were observed in CS-2-35.
Sequences after propagation in cell culture and SPF chicks
In this part of the study, the VP2 sequence region from nucleotide
759 to 1460 which includes the hypervariable sequence region of the
D78, ViBursa G and ViBursa CE vaccines was compared to that region of
GA-1, CS-2-35 andH-30 original viruses and those viruses after passage
in cell culture and SPF chickens. ViBursa G nucleotide and amino acid
sequenceswere identical to D78 across this region (Fig.1). Compared to
D78, ViBursa CE had two nucleotide mutations, one at 799 (G→A) and
one at 966 (A→C). Both produced amino acid changes when compared
to D78; amino acid position 223 changed from G→D and position 279
changed from N→H (Fig. 1). Thus, within the hypervariable VP2
sequence region, D78 and ViBursa G were identical and these vaccines
had one amino acid change compared to the original GA-1 isolate
(H253N), two amino acid changes compared to the original CS-2-35
isolate (H253Q and T269A) and two amino acid changes compared to
the original H-30 isolate (H253Q and G258D) (Fig. 1).
Cell-culture passed viruses
Following one passage in BGM-70 cell cultures, the GA-1 and CS-2-
35 viruses produced cytopathic effects (CPE) typical of IBDV strains
adapted to replicate in vitro. Two passes of the H-30 virus in these cells
were required to observe CPE. The sequences of the hypervariable
region of VP2 (nucleotides 759–1460) of these viruseswere determined
following one (GA-1cc and CS-2-35cc) or two (H-30cc) passes in cell
culture. The GA-1cc amino acid sequence was identical to the original
virus (GA-1) except for one amino acid change at position 253 (N→H)
(Fig. 1). The CS-2-35cc virus had two amino acids change compared to
the original isolate (CS-2-35); one at amino acid position 253 (Q→H)
and the other at 269 (A→T) (Fig. 1). The H-30cc virus had two amino
acid changes at positions 253 (Q→H) and 258 (D→G) (Fig. 1). The D78
and ViBursa G vaccines have H at amino acid position 253, G at position
258 and T at position 269. Thus, with these changes, the GA-1cc, CS-2-
35cc and H-30cc viruses had identical amino acid sequences compared
to D78 and ViBursa G across the VP2 hypervariable region (Fig. 1).
Cell-culture viruses following passage in SPF chickens
The viruses that were obtained from one or two passes in BGM-70
cells were then used to inoculate SPF chickens. The hypervariable
region of VP2 from 759 to 1460 was again sequenced from viruses
Fig. 2. Location of the nucleotide primers used for RT-PCR ampliﬁcation and nucleotide
sequencing. Numbers 1–15 correspond to the nucleotide primer sequences in Table 2.
The position of the ﬁrst nucleotide in the primer sequence is also listed at each arrow.
Fig. 1. Amino acid sequences of viruses from position 210 to 443 of the VP2 sequence.
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theGA-1cc-spf virus hadmutated back to the sequence observed in the
original viral isolate (GA-1). Amino acid 253 switched back from H in
the cell-culture virus (GA-1cc) to N in the in vivo passed virus (GA-1cc-
spf) (Fig.1). The CS-2-35cc-spf virus isolated from the SPF birds did not
change its amino acid sequence compared to the in vitro cell-culture
passed virus (CS-2-35cc). Similarly, the H-30cc-spf virus from the SPF
birds had a sequence identical to the cell-culture passed virus H-30cc.
Pathogenicity experiments
The GA-1 and CS-2-35 viruses were initially isolated from different
layer ﬂocks in Ohio and H-30 was from a breeder layer ﬂock in Iowa.
Our previous studies indicated that these viruses were pathogenic for
SPF chickens (Sreedevi et al., 2007). The results of those experiments
demonstrated that after 5 days post-inoculation, these viruses
produced signiﬁcantly smaller bursa compared to D78 vaccine
infected and un-infected controls. Pathology in the bursa of ﬁeld
virus inoculated chickens included greater than 75% central follicular
depletion with peri-follicular reticuloendothelial cell hyperplasia and
clear evidence of lymphocyte necrosis. Grossly, the bursa had a ﬁrm
yellowish color typical of an IBDV infection. No gross or histopatho-
logic lesions were observed in the D78 infected and un-inoculated
controls birds in those experiments (Sreedevi et al., 2007). Similar
results were observed when this challenge experiment was repeated
in the current study (data not shown).
Virulence of GA-1cc, CS-2-35cc and H-30cc
The cell-culture passed viruses were tested for virulence in three-
week-old SPF chickens. Gross and microscopic lesions in the bursawere observed in the birds inoculated with GA-1cc, CS-2-35cc and
H-30cc at 5 and 8 days post-inoculation. No lesions were observed in
the control birds at any time. Gross lesions in the GA-1cc, CS-2-35cc
and H-30cc infected birds consisted of yellow colored bursas that
had gelatinous coverings and were friable. Bursa–body weight ratios
at 5 days post-inoculation were not different from the controls and
D78 infected birds but at 8 days post-inoculation the GA-1cc, CS-2-
35cc and H-30cc infected birds had signiﬁcantly lower B/BW ratios
compared to the D78 infected and control birds (Table 1).
Histopathologic lesions in the GA-1cc infected bursas consisted of
moderate depletion of lymphocytes, variable loss of follicles and
reticuloendothelial cell proliferation with clear evidence of lympho-
cyte necrosis. These bursas were given a relative lesion score of 3. The
Table 1
Mean bursa–body weight (B–BW) ratios and the bursal score values of SPF chickens following inoculation with cell-culture passed GA-1cc, CS-2-35cc and H-30cc viruses
Group Day 5 post-infectionA Day 8 postinfectionB
B–BW ratio±SDC Bursal score B–BW ratio±SD Bursal score
GA-1cc 4.41±0.60a 3 2.49±0.61b 3
CS-2-35cc 4.37±0.66a 2 2.74±0.61b 2
H-30cc 4.63±0.49a 2 3.42±0.68b 2
D-78 5.54±0.71a 0 4.23±0.44a 0
Control 4.91±0.37a 0 5.90±1.26a 0
Values followed by different lowercase letters are signiﬁcantly different (Pb0.05).
A Values are average for four birds.
B Values are average for ﬁve birds.
C Bursa–body weight (B–BW) ratio was calculated by (bursa weight/body weight)×1000 and presented as the mean±standard deviation (SD) from each group.
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lymphocyte depletion with a variable loss of follicles. In these bursas
however, there was only a mild proliferation of reticuloendothelial
cells with some necrosis of lymphocytes. Their relative lesion scores
were 2 (Table 1). The control bursas and D78 infected bursas werewell
developed with full follicles, no lymphocyte depletion, and no
interstitial inﬂammation. Their relative lesion scores were 0 (Table 1).
Real-time RT-PCR
The nucleotide and amino acid sequences of the initial isolates GA-
1, CS-2-35 and H-30 changed when they were passed once in cell
culture (GA-1cc, CS-2-35cc and H-30cc). When these viruses were
passed back in SPF chickens, the sequence of the GA-1cc-spf virus
changed back to that of the original isolate (GA-1) while the CS-2-
35cc-spf and H-30cc-spf viruses remained similar to the in vitro
passed viruses CS-2-35cc and H-30cc, respectively. Since the CS-2-
35cc-spf and H-30cc-spf viruses were pathogenic in SPF chicks, we
suspected that a subpopulation of viruses with Q253 was present. The
real-time RT-PCR assay was designed to determine if these viruses had
Q253 (mutation probe 1) or N253 (mutation probe 2) sub-populations
(quasispecies) (Jackwood and Sommer, 2002). The GA-1cc-spf virus
examined with mutation probe 2 had melting point peaks at 49.9 °C
and 56.7 °C (data not shown). Two melting point peaks for GA-1cc-spf
indicated that two quasispecies of the virus existed in that sample. A
melting peak at approximately 56 °C indicated an exact sequence
match with this probe and conﬁrmed the N253 amino acid identiﬁed
in the sequence analysis. The CS-2-35cc-spf and H-30cc-spf viruses
had a dominant melting point peak at 56.9 °C using mutation probe 1
and several minor melting point peaks (data not shown). Multiple
melting point peaks for CS-2-35cc-spf and H-30cc-spf viruses also
indicated that they had other viral populations with mutations in thisTable 2
Primers used to amplify and sequence genome segments A and B
Primer Sequence 5′→3′ Direction
1 AGGATACGATGGGTCTGAC Forward
2 GCCCAGAGTCTACACCAT Forward
3 TACCGTTGTCCCATCAAAGC Reverse
4 GCAGGAGCATTCGGCTTC Forward
5 CCCGGATTATGTCTTTGA Reverse
6 GCCTTAGGTTGGCTGGTCCC Forward
7 CCACGTTGGCTGCTGC Reverse
8 AGGGGACCCGCGAACGGATCC Reverse
9 GGATACGATGGGTCTGACC Forward
10 CTTTGTAGCCGTTCTCTCTG Reverse
11 CGCACTACTCAAGCAGATG Forward
12 GTGGACTACCATATGTAGG Forward
13 ATACAGCAAAGATCTCGGG Forward
14 CAACACGGTCCAAGAACG Forward
15 GGGGGCCCCCGCAGGCG Reverse
Primers 1–8 were used for segment A sequences and primers 9–15 were used for
segment B sequences. Their locations on each genome segment are shown in Fig. 2.region of the genome but the melting point peak at 56 °C conﬁrmed
that viruses with amino acid Q253 were present in these samples.
Discussion
Bursa tissue samples from two geographically separate commer-
cial layer chicken ﬂocks in Ohio and one in Iowawere found to contain
IBDV. Our initial characterization of these viruses consisted of
sequencing the hypervariable region of the VP2 gene and pathogeni-
city studies (Sreedevi et al., 2007). Except for one nucleotide change at
position 888, the VP2 hypervariable region of the GA-1 isolate was
identical to attenuated strains of the virus. The D78 vaccine sequence
was used for comparison because D78 was used in this 43-day-old
ﬂock at 18 days of age. The H-30 virus also had two nucleotide changes
across the hypervariable region compared to the D78 vaccine which
was used in that ﬂock at 10, 14, 18, 22 and 29 days of age. A similar
situationwas observed for the CS-2-35 virus which was obtained from
a 35-day-old ﬂock that had been vaccinated with ViBursa G at 17 days
and ViBursa CE at 28 days of age. The CS-2-35 virus was most similar
to ViBursa G across the hypervariable region of VP2; it had two
nucleotide mutations at positions 890 and 936. Genetic mutations in
the hypervariable region of VP2 were commonly observed when IBDV
was passed in cell culture, embryonated chicken eggs and SPF
chickens (Yamaguchi et al., 2000; Smiley and Jackwood, 2001).
These initial sequencing results suggested that wemight have isolated
naturally occurring attenuated IBDV or closely related ancestors of the
vaccine viruses used in these layer ﬂocks except that our previous
workwith the GA-1, CS-2-35 and H-30 isolates also indicated that they
were pathogenic in SPF chickens; a result we did not expect (Sreedevi
et al., 2007). Taken together, this evidence suggests that these viruses
may be reversions from vaccine viruses or possibly pathogenic wild-
type IBDV strains that by coincidence are genetically similar to IBDV
vaccines. To further examine these suppositions, it was necessary to
determine if therewere mutations in other areas of the viral genomes.
To determine if other nucleotide and amino acid mutations had
occurred in the original GA-1, CS-2-35 and H-30 isolates their entire
genomes were sequenced. In addition the vaccine viruses D78,
ViBursa G and ViBursa CE were sequenced because these vaccines
were being used in the layer ﬂocks at the time GA-1, CS-2-35 and H-30
were isolated. All the vaccine viruses examined had identical genome
segment B sequences. Only one silent nucleotide mutation was
observed in genome segment B of each of the GA-1, H-30 and CS-2-
35 viruses compared to these vaccine strains; their VP1 amino acid
sequences were identical. This suggests that these viruses are closely
related and since VP1 was identical in all the viruses, it should not
impact their pathogenic phenotypes (Liu and Vakharia, 2004).
The GA-1 genome segment A sequence was very similar to the
attenuated D78 vaccine strain. There were two silent nucleotide
mutations at 2213 and 2236 in genome segment A of GA-1 compared
to D78 and the GA-1 virus had only one amino acid mutation (H253N)
compared to this vaccine virus. The two silent nucleotide mutations
at positions 2213 and 2236 were also observed in the H-30 virus.
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result suggests that GA-1 and H-30 are genetically related and have a
common ancestor. These viruses were isolated from distant geo-
graphic regions; one from Ohio and the other from Iowa. Based on our
previous epidemiologic studies, it would be rare to ﬁnd wild-type
IBDV strains from different geographic regions in the United States
with nearly identical nucleotide sequences because of the high
mutation rates (3.8×10−3 substitutions/site/year) observed in these
viruses (Jackwood and Sommer-Wagner, 2005; Owoade et al., 2004).
Evidence further supporting the hypothesis that these virus
isolates could be descendants from attenuated strains was the
mutation of three amino acids that have been linked to virulence in
classic strains of IBDV; Q253, D279 and A284 (Brandt et al., 2001). The
CS-2-35 and H-30 isolates had only one of the three amino acids at
these positions (Q253) and the GA-1 isolate did not have any of the
three amino acids linked to virulence. The amino acids Asparagine (N)
at position 279 and Threonine (T) at position 284 have also been
shown to be required for replication in cell culture (Mundt, 1999;
Yamaguchi et al., 1996b; Liu and Vakharia, 2004). The N279 and T284
found in GA-1, CS-2-35 and H-30 further supports our supposition
that these viruses are descendants of viruses that at one time were
adapted to replicate in cell culture. It is possible that wild-type IBDV
strains could naturally have N279 and T284, but to our knowledge
none have been documented. Because amino acids at positions 279
and 284 affect cell tropism (Mundt, 1999; van Loon et al., 2002) the
N279 and T284 mutations may reduce the ability of these viruses to
compete in vivo with strains that have D279 and A284. This further
supports the premise that N279 and T284 viruses would not naturally
persist in commercial chicken ﬂocks.
Compared directly to the D78 vaccine which produced little or no
lesions in the bursa of SPF chickens, GA-1 and H-30 produced
signiﬁcant gross and microscopic lesions in the bursa. The only
common geneticmutation shared by GA-1 and H-30was at amino acid
position 253. The GA-1 isolate had Asparagine (N253) and the H-30
isolate had Glutamine (Q253) at that position. Although previous
studies reported that three VP2 amino acids are involved in the control
of virulence in classic non-vvIBDV (Q253, D279 and A284) (Brandt
et al., 2001), our data support the conclusion that a mutation at only
the 253 amino acid is necessary to alter the virulence of a classic IBDV
strain. This is in agreement with data previously published by
Yamaguchi and coworkers (Yamaguchi et al. (2000). They found that
vaccine viruses hadHistidine at amino acid position 253 and that serial
passage of these vaccines in chickens caused a gradual shift fromH253
to G253. They also reported that viruseswith G253weremore virulent
than the H253 viruses and concluded that the viral populations in
vaccine strains of IBDV were easily selected by passage in chickens to
produce a G253 population or chicken embryo ﬁbroblast cells to
produce a H253 virus population. We observed the same results when
our viruses were passed in cell culture and then back into chickens
except H253 changed to N253 in GA-1 or Q253 in H-30 and CS-2-35. It
appears that H253 is necessary for attenuation and several amino acids
including Glycine, Asparagine or Glutamine at position 253 can
increase the virulence of the virus.
Further evidence supporting the hypothesis that GA-1 and H-30
are descendants of vaccine strains is the amino acid at position 76 in
VP2. The amino acid Glycine at this position appears to be rare in other
IBDV strains. A comparison of available GenBank sequences demon-
strated that they all had Serine at that position; only D78 had G76
(data not shown). The fact that both the GA-1 and H-30 viruses had
G76 is compelling evidence these viruses are descendants of the D78
vaccine. Although a quasispecies with Q253 or N253 may have been
present in the vaccines used in these ﬂocks (Jackwood and Sommer,
2002), it is also possible that the vaccine virus reverted to virulence via
a point mutation at position 253 (Yamaguchi et al., 2000). It should be
vigorously afﬁrmed that reversion of the D78 vaccine to virulence has
not been conclusively documented in our study when this vaccine isused according to the manufacturer's recommendations. This was not
the case of the Ohio and Iowa layer chicken ﬂocks where the GA-1 and
H-30 viruses were isolated. In both ﬂocks, D78 was being used at a
reduced dosage and contrary to the manufacturer's recommendation.
The CS-2-35 isolate was pathogenic in SPF chickens and our initial
sequencing studies suggested that it was very similar to ViBursa G, a
vaccine being used in the ﬂock of its origin (Sreedevi et al., 2007). After
sequencing the entire virus in this study, it became clear that CS-2-35
has several nucleotide and amino acid mutations compared to ViBursa
G and ViBursa CE, the other vaccine reportedly being used in this
ﬂock. When the entire genomes of CS-2-35 and D78 were compared,
3 amino acids were different; one was at the unique G76S position.
Because the amino acid at position 76 in CS-2-35 was Serine, this virus
may not be as closely related to D78 as GA-1 and H-30. The historical
use of D78 in this layer ﬂock is unknown. These data still suggest that
CS-2-35 may have evolved from an attenuated strain of IBDV but
maybe not D78.
Adapting IBDV strains to replicate in cell culture has historically
been used to attenuate these viruses. The amino acids N279 and T284
in VP2 were shown to be essential for replication in cell culture
(Mundt, 1999; Yamaguchi et al., 1996b). Albeit they were pathogenic,
because the GA-1, H-30 and CS-2-35 viruses all had N279 and T284 we
predicted they should have the ability to replicate in cell culture. The
GA-1 and CS-2-35 viruses produced CPE following the ﬁrst pass in
BGM-70 cells and H-30 produced CPE following only the second pass
in these cells. Adapting wild-type IBDV strains to replicate in cell
culture is difﬁcult and often requires numerous passes in culture.
Sequence analysis of the GA-1, H-30 and CS-2-35 cell-culture passed
viruses indicated that only one amino acid was changing in all three
isolates. Following one pass in cell culture, the amino acid at position
253 was changing from Asparagine (N) or Glutamine (Q) to the amino
acid Histidine (H). The amino acids N279 and T284 did not change in
any of the viruses suggesting that the amino acids at these positions
are not directly affecting pathogenicity of the viruses in vivo.
Challenge of SPF chickens with the viruses passed in cell culture
was conducted to determine if the change at amino acid position 253
affected their virulence. Based on gross and microscopic lesions in the
bursa, all three viruses were still pathogenic in chickens. Nucleotide
sequencing of the viruses obtained from the SPF chicken bursa
indicated that GA-1cc-spf had mutated back from H253 (cell culture)
to N253 (chick bursa). This mutation is consistent with our hypothesis
that position 253 is important for virulence. Sequencing the H-30cc-
spf and CS-2-35cc-spf viruses from the SPF chicken bursa indicated
that amino acid H253 did not mutate as it did in the GA-1cc-spf virus.
These viruses were pathogenic in SPF chickens albeit they were
slightly less virulent than the original isolates H-30 and CS-2-35 based
on histopathology. Sequence analysis will usually identify only the
dominant population of viruses in the sample. Thus, we suspected that
multiple populations (quasispecies) may be present in these samples.
Using real-time RT-PCR and melting point analysis, we previously
identiﬁed quasispecies in IBDV samples (Jackwood and Sommer, 2002).
The GA-1cc-spf virus had two distinct melting point peaks indicating at
least two distinct populations of IBDV. One of these melting peaks
corresponded to an exact sequence match with our probe indicating
that population of viruses had N253. When sequenced, the H-30cc-spf
and CS-2-35cc-spf viruses each had Histidine at position 253, but the
real-timeRT-PCRdata also demonstrated that one population in each of
these virus samples had Glutamine at that position. Although it is
impossible to tell which nucleotides are mutated and producing the
lower temperature melting point peaks, this data and the sequencing
data indicate that both Q253 and H253 IBDV populations were in the
H-30cc-spf and CS-2-35cc-spf samples.
The data from this study indicate that a single amino acid change at
position 253 can signiﬁcantly alter the virulence of IBDV. The amino
acid Histidine (H) at position 253 was associated with attenuation and
a substitution mutation to Asparagine (N) or Glutamine (Q) at this
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Materials and methods
Viruses
The GA-1 and CS-2-35 IBDV isolates were obtained from separate
commercial layer ﬂocks in Ohio and H-30 was from a layer breeder
ﬂock in Iowa (Sreedevi et al., 2007). The GA-1 virus was from a 43-day-
old ﬂock where the birds had been vaccinated with D78 (Intervet, Inc.,
Millsboro, DE) at 18 days of age andwith Bursine 2 (Fort Dodge Animal
Health, Fort Dodge, IA) at 28 days of age. The CS-2-35 virus was from a
35-day-old ﬂock vaccinated with ViBursa G at 17 days of age and
ViBursa CE at 28 days of age. The H-30 virus was from a 30-day-old
ﬂock vaccinated with a half dose each of D78 and Bursine 2 at 10, 14,
18, 22 and 29 days of age.
In all three ﬂocks, the birds had decreased feed consumption and
slightly higher than expected mortality. In addition, bursa from birds
randomly selected from the ﬂocks had gross lesions in the bursa that
are typical of IBD. These viruses were previously determined to be
pathogenic in three-week-old SPF chickens (Sreedevi et al., 2007).
Nucleotide sequence analysis
Viral RNA extraction
Bursa were homogenized in TNE buffer (10 mM Tris–HCl, pH 8.0,
100 mM NaCl, 1 mM EDTA) and frozen and thawed three times. A
300 μl volume of the bursa homogenate was extracted with 900 μl of
Trizol (Invitrogen Corp., Carlsbad, CA). The solution was subjected to
centrifugation at 12,000 ×g for 5 min at 4 °C. The supernatant was
removed and extracted with an equal volume of chloroform.
Following a 5 min incubation at room temperature, the supernatant
was collected by centrifugation at 12,000 ×g for 15 min. Viral RNA in
the supernatant was precipitatedwith an equal volume of isopropanol
and collected using centrifugation at 12,000 ×g for 30 min at 4 °C. The
RNA pellet was rinsed once with 75% ethanol and suspended in 20 μl
of 90% dimethyl sulfoxide until used.
RT-PCR ampliﬁcation
The GeneAmp RNA PCR kit (Perkin Elmer, Roche Molecular
Systems Inc., Branchburg, NJ) was used according to the manufac-
turer's instructions. The RNA was denatured at 95 °C for 5 min and
then incubated at 42 °C for 1 h in the RT reaction. Following RT, the
samples were denatured at 95 °C for 2 min, and then 35 cycles of PCR
were conducted at 95 °C for 1 min, 53 °C for 1.5 min and 72 °C for
1 min. After the last cycle, an incubation at 72 °C for 7 min was added
to extend the products.
Nucleotide sequencing
Genome segments A and B of GA-1, CS-2-35, H-30 and the vaccine
strains D78, ViBursa G and ViBursa CE were sequenced in their
entirety. The primers used are listed in Table 2 and their locations on
the genome are shown in Fig. 2. Segment A was ampliﬁed in sections
using four sets of primers; 1 and 3, 2 and 5, 4 and 7 and 6 and 8. Each
section was sent for cycle sequencing using the ampliﬁcation primers.
Segment B was ampliﬁed in its entirety using one set of primers; 9 and
15. This full-length RT-PCR product was then sent for cycle sequencing
using the ampliﬁcation primers 9 and 15 and ﬁve additional primers;
10, 11, 12, 13 and 14 (Table 2). For some experiments, only the
hypervariable region of VP2 was sequenced. The primers used to
generate RT-PCR products of this region were 2 and 5 (Table 2).
TheRT-PCRproductswereprepared fornucleotide sequencingusing a
Geneclean spin kit (BIO 101; Vista, CA) as previously described (Jackwood
et al., 2001). Cycle sequencing was conducted at the University of
Wisconsin, Biotechnology Center, DNA Sequence Laboratory (Madison,WI). Nucleotide sequences were downloaded using Chromas (Technely-
sium Pty Ltd., Queensland, Australia) and analyzed using Omiga software
(OxfordMolecular, Campbell, CA). TheGenBankaccessionnumbersof the
segment A sequences used in the present study include D78 (EU162087),
ViBursa G (EU162088), ViBursa CE (EU162089), GA-1 (EF418034), H-30
(EF418035), and CS-2-35 (EF418033). The GenBank accession numbers
for the Segment B sequences used in this study are D78 (EU162090),
ViBursa G (EU162091), ViBursa CE (EU162092), GA-1 (EU162094), H-30
(EU162095) and CS-2-35 (EU162093).
Real-time RT-PCR
Assays were conducted using a LightCycler instrument (Idaho
Technology Inc., Idaho Falls, ID) and Light Cycler-RNA ampliﬁcation kit
for hybridization probes (Roche, Molecular biochemicals, Alamedia,
CA.). This assay has been used in our laboratory to identify
quasispecies of IBDV (Jackwood and Sommer, 2002). The reaction
mix contained 4 µl 5X RT-PCR reaction mix, 0.25 µM of each primer,
4.5 mM MgCl2, 0.2 µM of each probe, 0.5 µl viral RNA and H2O for a
ﬁnal volume of 20 µl. Primers 2 and 5 were used to amplify the
genome (Table 2). The probes used to detect the RT-PCR products were
located over the minor peak region that codes for amino acid 253.
Mutation probe 1 5′-TCAAACAAGCGTCCAAGGTCTTG-FITC-3′ and
anchor probe 5′-Red 640-CTGGGCGCCACCATCTACTTTATAGGCTTTG-
3′ were previously described (Mickael and Jackwood, 2005). Mutation
probe 1 was designed to identify the nucleotide coding sequence for
the amino acid Q253. We also used mutation probe 2 5′-TCAAA-
CAAGCGTCAACGGTCTTG-FITC-3′ with the anchor probe to identify
the nucleotide coding sequence for amino acid N253. These probes
were constructed by IT BioChem (Salt Lake City, UT). Incubations in the
LightCycler include an RT step at 55 °C for 7 min and a denaturation
step at 95 °C for 5 min. This was followed by 40 cycles at 95 °C for 1 s,
62 °C for 10 s and 72 °C for 30 s. Following real-time RT-PCR the
products were analyzed for multiple IBDV strains using melting peak
analysis as previously described (Jackwood and Sommer-Wagner,
2005; Jackwood and Sommer, 2002).
In vitro propagation
BGM-70 cells (Dahling and Wright, 1986) were propagated in
Dulbecco's Modiﬁed Eagle Medium (Gibco, Invitrogen Corp.) and used
to determine if the wild-type viruses were capable of growth in vitro.
Bursas containing each isolate were homogenized in TNE buffer,
clariﬁed using low-speed centrifugation and the supernatant was
passed through a 0.22 µm syringe ﬁlter (Acrodisc, PF, Gelman Sciences,
Ann Arbor, MI). The efﬂuent was used to inoculate 85–90% conﬂuent
monolayers of the BGM-70 cells in 75 cm2 cell-culture ﬂasks (Corning
Inc., Corning, NY). A 0.5 ml volume of virus was inoculated into each
ﬂask and the cells were maintained in a 5% CO2 environment at 37 °C
for aminimumof 5 days or until cytopathic effects (CPE) were evident.
At that time, the cells and media were collected, frozen and thawed
three times and the suspensionwas clariﬁed by low-speed centrifuga-
tion. The supernatant ﬂuid was collected, aliquoted and stored at
−70 °C until used for RT-PCR, sequencing and pathogenicity experi-
ments. An age-matched un-inoculated ﬂask of BGM-70 cells was
included in each experiment. It was used to estimate the percent CPE
by direct comparison with the virus inoculated cells.
Pathogenicity experiments
The GA-1, CS-2-35 and H-30 viruses were previously determined
to be virulent in three-week-old speciﬁc pathogen-free (SPF) chickens
(Charles River laboratories, North Franklin, CT, USA) (Sreedevi et al.,
2007). In that study, we compared the pathogenicity of these ﬁeld
isolates to the vaccine strain D78. In the current study, we passed the
original GA-1 and CS-2-35 isolates once in vitro and then sequenced
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because no CPE was observed following the ﬁrst pass. These in vitro
passed viruses were then tested for pathogenicity in SPF chickens.
Three-week-old SPF chickens were housed in isolators and given
water and feed ad libitum. The viruses in BGM-70 cells were harvested
by three cycles of freezing and thawing. The resulting cell-culture
solution was used to inoculate three-week-old SPF chicks. A 0.1 ml
volume of the cell culture–virus suspensions was inoculated via the
oral–nasal route into each of nine SPF chickens. The viral titers in this
volume for the GA-1, CS-2-35, H-30 and D78 viruses were adjusted to
be 1×103 mean tissue culture infectious doses (TCID50).
Three groups containing 9 birds each were inoculated with the cell-
culture (cc) grownGA-1cc, CS-2-35cc andH-30ccviruses. A fourthgroup
of 9birdswaskept asun-inoculated controls. Fourbirds fromeachgroup
were sacriﬁced on day 5 post-inoculation and the remaining 5 birds on
day 8 post-inoculation. The bursa and bodyweightsweremeasured and
bursa–body weight ratios (B–BW) were calculated (bursa weight (g)/
body weight (g)×1000). At necropsy, the bursa were excised into two
equal halves for viral RNA extraction and histopathological studies.
Histopathology of bursa samples
Bursal tissueswereﬁxed in 10%buffered formalin andprocessed for
histopathology by standard methods of parafﬁn embedding, section-
ing and hematoxylin and eosin staining (Tanimura et al., 1995). The
tissue sections were examined by light microscopy and the severity of
the lesions were graded based on the extent of the lymphocyte
necrosis, follicular depletion and atrophy. Scores of 0 to 4 were used to
indicate relative degree of severity, a score of ‘0’indicated absence of
lesions, and scores 1 to 4 were for b25%, 25 to 50%, 50 to 75% and N75%
of follicles affected, respectively.
Statistical analysis
The B:BW ratios were compared by ANOVA and Fisher's least
squares test for differences among the groups.
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